About Zandoriah®
Explore the Key Details
Zandoriah® (teriparatide) is a prescription treatment designed for adults living with osteoporosis and facing a higher risk of fractures, including postmenopausal women, men with osteoporosis, and patients receiving long-term glucocorticoid therapy.
Comparison:
Laboratory studies have shown that the active substance in Zandoriah® is highly similar to that in Forsteo in terms of structure, purity and biological activity.
Zandoriah at a Glance
For Postmenopausal Women, Men with Osteoporosis, and People on Long-Term Glucocorticoid Therapy
Supporting Bone Strength and Reducing Osteoporotic Fracture Risk
Comparable Quality, Safety, and Efficacy to the Reference Product
Built on CinnaGen's High Standards of Quality and Excellence
We Make Hope Accessible
We bring high-quality biosimilars to patients who need them,
Safety Information:
The safety of Zandoriah® has been evaluated and, based on all the studies carried out, the side effects of the medicine are considered to be comparable to those of Forsteo.